Details for Patent: 8,653,137
✉ Email this page to a colleague
Which drugs does patent 8,653,137 protect, and when does it expire?
Patent 8,653,137 protects REMODULIN and is included in one NDA.
This patent has sixteen patent family members in seven countries.
Summary for Patent: 8,653,137
| Title: | Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| Abstract: | Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reducing the occurrence of blood stream infections in a mammal is also provided. |
| Inventor(s): | Jeffs; Roger Andrew (Chapel Hill, NC), Zaccardelli; David (Cary, NC) |
| Assignee: | United Therapeutics Corporation (Silver Spring, MD) |
| Application Number: | 13/912,753 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,653,137 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; |
Drugs Protected by US Patent 8,653,137
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Therap | REMODULIN | treprostinil | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 021272-007 | Sep 28, 2023 | RX | Yes | Yes | 8,653,137 | ⤷ Subscribe | ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE DILUENT FOR FLOLAN OR STERILE DILUENT FOR EPOPROSTENOL SODIUM PRIOR TO ADMINISTRATION | ⤷ Subscribe | ||||
| United Therap | REMODULIN | treprostinil | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 021272-008 | Sep 28, 2023 | RX | Yes | Yes | 8,653,137 | ⤷ Subscribe | ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE DILUENT FOR FLOLAN OR STERILE DILUENT FOR EPOPROSTENOL SODIUM PRIOR TO ADMINISTRATION | ⤷ Subscribe | ||||
| United Therap | REMODULIN | treprostinil | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 021272-001 | May 21, 2002 | AP | RX | Yes | Yes | 8,653,137 | ⤷ Subscribe | ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE DILUENT FOR FLOLAN OR STERILE DILUENT FOR EPOPROSTENOL SODIUM PRIOR TO ADMINISTRATION | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,653,137
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2698721 | ⤷ Subscribe | |||
| China | 101827612 | ⤷ Subscribe | |||
| China | 103181893 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
